Disclosed is a pharmaceutical composition for the prevention or treatment ofblood clotting disorder which can reduce a burden on a patient. The pharmaceuticalcomposition comprises an effective amount of ribavirin or a derivative thereofor a pharmaceutically acceptable salt of ribavirin or the derivative.